Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

SIDEROSENSE Siderophore-mediated delivery of antibacterial antisense agents

Coordinator
Stichting Radboud Universiteit, Netherlands
Runs
1 December 2026 to 31 May 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101334519

What the project is doing

In the project's own words, from its summary on CORDIS.

Antibacterial resistance represents a major and growing threat to global public health, while the development of new antibiotics with novel mechanisms of action has largely stagnated. The SIDEROSENSE project addresses this challenge by advancing a fundamentally new antibacterial modality based on antisense technology. SIDEROSENSE enables selective intracellular delivery of antibacterial antisense oligonucleotides, overcoming a long-standing barrier to the clinical translation of antisense-based antibacterials.

Proof-of-principle studies have demonstrated potent antibacterial activity. This ERC Proof of Concept project aims to establish whether the SIDEROSENSE technology translates into a safe and effective antibacterial strategy. The project will generate critical experimental data, while simultaneously strengthening the IP position and assessing regulatory and commercial pathways. In parallel, a market and exploitation strategy will be developed to support informed go/no-go decisions and downstream translation.

SIDEROSENSE will deliver the essential technical and strategic validation required to assess the feasibility of antisense-based antibiotics as a new therapeutic class and to position the technology for subsequent translational funding and clinical development.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Radboud UniversiteitNijmegenNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI